Clinical Trial Update: Study of Propranolol in Newly Diagnosed Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating propranolol in patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Propranolol (propranolol)

Snippet

Sponsor: Columbia University | Conditions: Locally Advanced Malignant Neoplasm, Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2020-01-10